高级检索
当前位置: 首页 > 详情页

Personalized medicine of esophageal cancer

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Cardiothoracic Surgery, Hebei Medical University Fourth Hospital, ShiJiaZhuang, Hebei, P. R. China [2]SurExam Bio-Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou, P. R. China
出处:
ISSN:

关键词: Biomarker drug response esophageal carcinomas

摘要:
The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend. This review presents several biomarkers of esophageal cancer, including chemotherapy-related biomarkers and targeted drug-related biomarkers, and the correlation of these biomarkers with drug response.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2012]版:
Q4 ONCOLOGY
最新[2024]版:
Q4 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Department of Cardiothoracic Surgery, Hebei Medical University Fourth Hospital, ShiJiaZhuang, Hebei, P. R. China
通讯作者:
通讯机构: [2]SurExam Bio-Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou, P. R. China [*1]SurExam Bio-Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42315 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号